Press release
Refractory Multiple Myeloma Market Size 2024-Industry Share, Growth, Trends, Revenue Analysis, Top Leaders-Bristol Myers Squibb, Teva Pharmaceutical Industries Ltd., Pfizer Inc.
Refractory Multiple Myeloma Market || 2024-2031
Get a Free Sample PDF - https://datamintelligence.com/download-sample/refractory-multiple-myeloma-market
What is the projected growth rate (CAGR) of the Global Refractory Multiple Myeloma market from 2024 to 2031, and what is the market value expected to change by 2031?
The Global Refractory Multiple Myeloma Market reached USD 2.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 3.4 billion by 2031. The Global Refractory Multiple Myeloma Market is expected to exhibit a CAGR of 4.7% during the forecast period 2024-2031.
What is Refractory Multiple Myeloma Market?
The Refractory Multiple Myeloma market focuses on the treatment of multiple myeloma (MM) that is resistant to standard therapies. Refractory MM poses significant challenges due to its aggressive nature and the limited effectiveness of conventional treatments, necessitating the development of novel therapeutic options. This market includes various treatment modalities, such as monoclonal antibodies, proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapies.
Who are the major players in the Refractory Multiple Myeloma market?
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Refractory Multiple Myeloma market research report are: Bristol Myers Squibb, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Janssen Global Services, LLC, Gilead Sciences, Inc., Fresenius Kabi, GSK plc., Novartis AG, Takeda Pharmaceutical Company Limited and Genentech, Inc. among others.
Key Development
On June 6, 2023, Johnson & Johnson's Janssen Pharmaceutical announced the filing of a supplementary biologics license application (sBLA) with the U.S. FDA. This application seeks approval for an additional indication for the use of CARVYKTI (ciltacabtagene autoleucel; cilta-cel) as a treatment option for adults diagnosed with refractory or relapsed multiple myeloma who have received at least one prior line of therapy.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=refractory-multiple-myeloma-market
Regions Covered:
The global Refractory Multiple Myeloma Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Market Segments
By Drug Type: Proteasome Inhibitor, Immunomodulators, Anti-CD38 Monoclonal Antibody, Others.
By Route of Administration: Oral, Parenteral.
By Product Type: Tablet, Capsule, Solution, Suspension.
By End User: Hospitals, Surgical Centers/ Clinics, Others.
The Refractory Multiple Myeloma industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
➥ Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
➥ Meet critical unmet needs in complex conditions with advanced, precise Refractory Multiple Myeloma industry solutions for better diagnostics and outcomes.
➥ Stay ahead with real-time pipeline analysis, revealing the latest Refractory Multiple Myeloma innovations and market trends.
➥ Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
➥ Protect your innovation with expert patent analysis, ensuring strategic positioning in the Refractory Multiple Myeloma market.
➥ Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Refractory Multiple Myeloma
➥ Maximize market presence with brand share analysis, strengthening your position in the Refractory Multiple Myeloma landscape.
➥ Accurately predict market demand for Refractory Multiple Myeloma with precise drug sales forecasting insights.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/refractory-multiple-myeloma-market
FAQs
What does the Refractory Multiple Myeloma market report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
What is the scope of the market report?
The market report covers regional analysis and provides detailed insights into the Refractory Multiple Myeloma market including market size, segmentation, and key players.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Refractory Multiple Myeloma Market Size 2024-Industry Share, Growth, Trends, Revenue Analysis, Top Leaders-Bristol Myers Squibb, Teva Pharmaceutical Industries Ltd., Pfizer Inc. here
News-ID: 3714218 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Refractory
Refractory Recycling Market May See a Big Move | Alfaref GmbH, Zarin Refractory, …
Advance Market Analytics published a new research publication on "Refractory Recycling Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Refractory Recycling market was mainly driven by the increasing R&D spending across the world.
Get inside Scoop of the report, request…
Checkpoint Inhibitor Refractory Cancer Market
Checkpoint Inhibitor Refractory Cancer Market Overview
The global Checkpoint Inhibitor Refractory Cancer Market is poised for significant growth, anticipating a high CAGR during the forecast period from 2023 to 2030.
Understanding Checkpoint Inhibitor Refractory Cancer
Refractory cancer, which might not respond to treatments immediately or might develop resistance later, has driven significant growth and transformation in the global checkpoint inhibitor refractory cancer market. The interest of oncologists in the potential antitumor activity of…
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991
This latest report researches the…
Zirconium Corundum Brick Market Booming Worldwide( Forecast Period 2023-2029) Wi …
The global Zirconium Corundum Brick market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Zirconium Corundum Brick market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of…
Refractory Recycling Market is Booming Worldwide By Leading Players - SEBOREF s. …
This Refractory Recycling Market research report offers you an array of insights about Automotive industry and business solutions that will support to stay ahead of the competition. Systematic investment analysis is also underlined in this Refractory Recycling Market report which forecasts impending opportunities for the market players.This market report is the outcome of persistent efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carries out detailed and diligent…
Mullite Brick market 2018-19 Changxing Refractory,Zhengzhou Sunrise Refractory , …
Mullite Brick market Competitor Analysis:
Global Mullite Brick market 2019 by Future Market Reports presents a professional and complete analysis of on the current Industry situation. The Global report includes Mullite Brick Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Mullite Brick market players and the future prospects from various angles in detail. Industry…
